A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

The popularity of GLP-1R drugs has catapulted the treatment landscape of obesity into the spotlight. Reformation for the ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Key rules on Medicare Advantage, telehealth and the No Surprises Act likely will be left for the Trump administration to ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Pfizer is cutting costs and refocussing its research and development (R&D) operations in a bid to maintain and grow ...

Aragen, based in Hyderabad, says it will use the funds to boost manufacturing capacity for newer treatment modalities, such ...

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address ...